Clauszoline MCAS# 187110-72-1 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 187110-72-1 | SDF | Download SDF |
| PubChem ID | 10823162 | Appearance | Yellow powder |
| Formula | C13H9NO3 | M.Wt | 227.22 |
| Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 2,8-dihydroxy-9H-carbazole-3-carbaldehyde | ||
| SMILES | C1=CC2=C(C(=C1)O)NC3=CC(=C(C=C23)C=O)O | ||
| Standard InChIKey | IGPNSSMZXGKMGU-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C13H9NO3/c15-6-7-4-9-8-2-1-3-11(16)13(8)14-10(9)5-12(7)17/h1-6,14,16-17H | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Clauszoline M shows a significant anti-tuberculosis activity. |
| Targets | Antifection |
Clauszoline M Dilution Calculator
Clauszoline M Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 4.401 mL | 22.0051 mL | 44.0102 mL | 88.0204 mL | 110.0255 mL |
| 5 mM | 0.8802 mL | 4.401 mL | 8.802 mL | 17.6041 mL | 22.0051 mL |
| 10 mM | 0.4401 mL | 2.2005 mL | 4.401 mL | 8.802 mL | 11.0026 mL |
| 50 mM | 0.088 mL | 0.4401 mL | 0.8802 mL | 1.7604 mL | 2.2005 mL |
| 100 mM | 0.044 mL | 0.2201 mL | 0.4401 mL | 0.8802 mL | 1.1003 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- NS309
Catalog No.:BCC1809
CAS No.:18711-16-5
- N,N'-Bis(2-hydroxyethyl)oxamide
Catalog No.:BCC9061
CAS No.:1871-89-2
- Sinapine
Catalog No.:BCN1815
CAS No.:18696-26-9
- Pafuramidine
Catalog No.:BCC1832
CAS No.:186953-56-0
- 2B-(SP)
Catalog No.:BCC5817
CAS No.:186901-17-7
- Moxifloxacin HCl
Catalog No.:BCC2507
CAS No.:186826-86-8
- ML 10302 hydrochloride
Catalog No.:BCC7695
CAS No.:186826-17-5
- Ginsenoside Rg5
Catalog No.:BCN3551
CAS No.:186763-78-0
- Alisol A 24-acetate
Catalog No.:BCN2344
CAS No.:18674-16-3
- N6-methyladenosine (m6A)
Catalog No.:BCC6495
CAS No.:1867-73-8
- Ketamine hydrochloride
Catalog No.:BCC5982
CAS No.:1867-66-9
- H-D-Tyr(tBu)-OH
Catalog No.:BCC3137
CAS No.:186698-58-8
- Luliconazole
Catalog No.:BCC1711
CAS No.:187164-19-8
- Cyanidin-3-O-rutinoside chloride
Catalog No.:BCN3114
CAS No.:18719-76-1
- Oseltamivir acid
Catalog No.:BCC1826
CAS No.:187227-45-8
- PA-824
Catalog No.:BCC1106
CAS No.:187235-37-6
- Kimcuongin
Catalog No.:BCN7472
CAS No.:1872403-23-0
- Z-VAD-FMK
Catalog No.:BCC1126
CAS No.:187389-52-2
- Boc-D-FMK
Catalog No.:BCC1128
CAS No.:187389-53-3,634911-80-1
- ER 50891
Catalog No.:BCC7783
CAS No.:187400-85-7
- Methylisopelletierine
Catalog No.:BCN1160
CAS No.:18747-42-7
- Sitoindoside I
Catalog No.:BCN1161
CAS No.:18749-71-8
- N-Aminophthalimide
Catalog No.:BCC9085
CAS No.:1875-48-5
- MaxiPost
Catalog No.:BCC7984
CAS No.:187523-35-9
Chemical constituents of Clausena excavata: isolation and structure elucidation of novel furanone-coumarins with inhibitory effects for tumor-promotion.[Pubmed:11000023]
J Nat Prod. 2000 Sep;63(9):1218-24.
A study of the chemical constituents of the leaves of Clausena excavata cultivated in a greenhouse led to the isolation and identification of 10 new furanone-coumarins named clauslactones A (1), B (2), C (3), D (4), E (5), F (6), G (7), H (8), I (9), and J (10), together with a known carbazole, Clauszoline M, and a coumarin, umbelliferone. The new coumarins contain a C(10) terpenoid side chain with a furanone (gamma-lactone) moiety. Further, in clauslactones A-D (1-4), the terpenoid side chain was shown to be linked to the 7,8-dioxygenated coumarin skeleton through a 1, 4-dioxane ring system. This is the first example of coumarins with these structural characteristics in nature. These furanone-coumarins were found to exhibit inhibitory activity against 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus early antigen activation in Raji cells.
Induction of cell cycle arrest by the carbazole alkaloid Clauszoline-I from Clausena vestita D. D. Tao via inhibition of the PKCdelta phosphorylation.[Pubmed:22093759]
Eur J Med Chem. 2012 Jan;47(1):214-20.
Sixteen carbazole alkaloids from Clausena vestita D. D. Tao were extracted, and their anti-tumor activities were evaluated. Among the extracts, Clauszoline-I exhibited an obvious growth inhibitory activity against several cancer cell lines through its ability to induce cell cycle arrest in the S and G2/M phases. A dramatic morphologic change with decreased F-actin staining and RhoA activity was found in Clauszoline-I treated HepG2 cells, in which the phosphorylation of PKCdelta (Ser643) was inhibited. Our results indicated that induction cell cycle arrest by Clauszoline-I might be achieved by decreasing the RhoA activity via the inhibition of PKCdelta phosphorylation.
First total synthesis of the 7-oxygenated carbazole alkaloids clauszoline-K, 3-formyl-7-hydroxycarbazole, clausine M, clausine N and the anti-HIV active siamenol using a highly efficient palladium-catalyzed approach.[Pubmed:17036106]
Org Biomol Chem. 2006 Sep 7;4(17):3215-9.
Using a convergent palladium-catalyzed construction of the carbazole framework as the key step we have achieved a short synthesis of the 7-oxygenated carbazole alkaloids clauszoline-K, 3-formyl-7-hydroxycarbazole, clausine C (clauszoline-L), clausine M, clausine N and the anti-HIV active siamenol.
Anti-tuberculosis activity and structure-activity relationships of oxygenated tricyclic carbazole alkaloids and synthetic derivatives.[Pubmed:28094223]
Bioorg Med Chem. 2017 Nov 15;25(22):6167-6174.
A series of 49 oxygenated tricyclic carbazole derivatives has been tested for inhibition of the growth of Mycobacterium tuberculosis and a mammalian cell line (vero cells). From this series, twelve carbazoles showed a significant anti-TB activity. The four most active compounds were the naturally occurring carbazole alkaloids clauszoline-M (45), murrayaline-C (41), carbalexin-C (27), and the synthetic carbazole derivative 22 with MIC90 values ranging from 1.5 to 3.7muM. The active compounds were virtually nontoxic for the mammalian cell line in the concentration range up to 50muM.
